drugset / Trial / NCT03380624

Tear Lipid Layer Thickness With Emollient Eye Drops

NCT03380624

Phase 4 Completed 21 enrolled Ohio State University Allergan · collab
RandomizedCrossoverDouble-blindTreatment

Summary

Crossover comparison of lipid layer thickness with two artificial tear formulations

Timeline

Start
2017-03-01
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Optive Lubricant Eye Drops Unknown 1 unknown Other
Subject Refresh Optive MEGA-3 Other / unclassified 1 unknown Other

Indications